Aemetis Inc

Aemetis Inc(AMTX)股票分析

$1.200

-0.066 (-5.51%)收盘时

Loading chart…
最高
1.280
开盘
1.260
成交量加权均价
1.22
成交量
1.15M
市值
134.08M
最低
1.175
成交额
1.40M
企业价值/息税折旧摊销前利润(TTM)
11.62

Aemetis, Inc. is a renewable natural gas and renewable fuels company. The Company focused on the operation, acquisition, development and commercialization of technologies that lower fuel costs and reduce emissions. The Company’s segments include California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The California Ethanol segment consists of an approximately 65 million gallons per year ethanol plant in Keyes, California. The California Dairy Renewable Natural Gas segment is engaged in the production and sale of renewable natural gas and associated environmental attributes, consisting of anaerobic digesters located at diaries, a 36-mile biogas collection pipeline, and a biogas upgrading hub and pipeline interconnect that produces Renewable Natural Gas from the biogas. The India Biodiesel segment includes a biodiesel production plant in Kakinada, India with a production capacity of over 80 million gallons per year and administrative offices in Hyderabad, India.

AI 分析 of Aemetis Inc (AMTX)

卖出

Aemetis Inc (AMTX) is not a good buy right now. The current price is $1.46, and the RSI is at a very low 20.68, indicating oversold conditions. However, the company's financials show significant losses, with a net income of -$21.71 million in Q1 2026 and a gross margin of only 5.05%. Additionally, the stock has dropped 50.84% over the past year, reflecting ongoing struggles. The main risk is the forward P/E of 58.82, suggesting that investors are expecting substantial future growth that may not materialize given the current financial performance.

分析师评级(1)

上行空间 +1566.67%
持有
0 买入
1 持有
0 卖出
当前: 1.20
最低
20.00
平均
20.00
最高
20.00

Ascendiant

2025-06-06

目标价

$20

买入

UBS

2025-05-09

目标价

—

买入

Ascendiant Capital

2025-03-17

目标价

$19

强烈买入

HC Wainwright & Co.

2025-03-14

目标价

$28

强烈买入

HC Wainwright & Co.

2024-12-23

目标价

$28

强烈买入

估值指标

Aemetis Inc(AMTX)当前预期市盈率为 58.82,5 年平均预期市盈率为 4.40。

预期市盈率

严重高估
5 年均值 P/E
4.40
当前P/E
58.82
高估
26.08
低估
-17.27

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
60.95
当前EV/EBITDA
11.62
高估
334.38
低估
-212.49

预期市销率

合理
5 年均值 P/S
0.60
当前P/S
0.26
高估
1.10
低估
0.10

Alphio AI 对 AMTX 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%AMTX

$1.94

情景价格

基

基准

基准 · 50%AMTX

$1.60

情景价格

悲

悲观

悲观 · 25%AMTX

$1.00

情景价格

事件时间线

2026-08-06 (ET)

09:30:00

Aemetis Q2 Revenue at $62.7M, Below Expectations

2026-05-07 (ET)

09:20:00

Aemetis Reports Q1 Revenue of $54.62M

2026-03-12 (ET)

08:10:00

Aemetis Q4 Revenue $43.307M, Below Consensus

2026-02-03 (ET)

08:30:00

Aemetis Subsidiary Secures $24M Biodiesel Orders

2025-12-30 (ET)

08:10:00

Aemetis Secures $17M in Federal Clean Energy Tax Credits

资讯

AMTX 常见问题 —— 由 Alphio AI 解答

Aemetis, Inc. is a renewable natural gas and renewable fuels company. The Company focused on the operation, acquisition, development and commercialization of technologies that lower fuel costs and reduce emissions. The Company’s segments include California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The California Ethanol segment consists of an approximately 65 million gallons per year ethanol plant in Keyes, California. The California Dairy Renewable Natural Gas segment is engaged in the production and sale of renewable natural gas and associated environmental attributes, consisting of anaerobic digesters located at diaries, a 36-mile biogas collection pipeline, and a biogas upgrading hub and pipeline interconnect that produces Renewable Natural Gas from the biogas. The India Biodiesel segment includes a biodiesel production plant in Kakinada, India with a production capacity of over 80 million gallons per year and administrative offices in Hyderabad, India. It operates in the Energy sector (INDUSTRIAL ORGANIC CHEMICALS industry).

Aemetis Inc (AMTX) is not a good buy right now. The current price is $1.46, and the RSI is at a very low 20.68, indicating oversold conditions. However, the company's financials show significant losses, with a net income of -$21.71 million in Q1 2026 and a gross margin of only 5.05%. Additionally, the stock has dropped 50.84% over the past year, reflecting ongoing struggles. The main risk is the forward P/E of 58.82, suggesting that investors are expecting substantial future growth that may not materialize given the current financial performance.

1 analysts cover AMTX: 0 rate it Buy, 1 Hold and 0 Sell. The average price target is 20.00.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易